Related Experiment Video
Updated: Jan 19, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
When encephalitogenic T cells collaborate with microglia in multiple sclerosis
1Hotchkiss Brain Institute and the Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Abstract:
Immune cells mediate critical inflammatory and neurodegenerative processes in the CNS in individuals with multiple sclerosis (MS). In MS, activated microglia, border-associated macrophages and monocyte-derived macrophages in the CNS can encounter T cells that have infiltrated the brain parenchyma from the circulation. Although microglia and T cells both contribute to normal CNS development and homeostasis, evidence suggests that the meeting of activated microglia and macrophages with encephalitogenic T cells exacerbates their capacity to inflict injury. This crosstalk involves many cell-surface molecules, cytokines and neurotoxic factors. In this Review, we summarize the mechanisms and consequences of T cell-microglia interactions as identified with in vitro experiments and animal models, and discuss the challenges that arise when translating this preclinical knowledge to MS in humans. We also consider therapeutic approaches to MS of which the mechanisms involve prevention or modulation of T cell and microglia responses and their interactions.
Insights
In multiple sclerosis (MS), interactions between T cells and microglia worsen neuroinflammation and damage. Targeting these immune cell communications may offer new therapeutic strategies for MS.
Area of Science:
- Neuroimmunology
- Neuroinflammation
- Multiple Sclerosis Pathogenesis
Background:
- Immune cells, including microglia and T cells, play key roles in the central nervous system (CNS).
- In multiple sclerosis (MS), interactions between activated microglia and infiltrating T cells can exacerbate CNS injury.
- This crosstalk involves complex molecular signaling pathways.
Purpose of the Study:
- To review the mechanisms and consequences of T cell-microglia interactions in MS.
- To discuss the translation of preclinical findings to human MS.
- To explore therapeutic strategies targeting these interactions.
Main Methods:
- Review of in vitro experiments and animal models of T cell-microglia interactions.
- Analysis of cell-surface molecules, cytokines, and neurotoxic factors involved.
- Discussion of challenges in translating preclinical data to human MS.
Main Results:
- T cell-microglia interactions amplify neuroinflammatory and neurodegenerative processes in MS.
- Specific molecular crosstalk mechanisms contribute to disease exacerbation.
- Preclinical models provide insights into disease mechanisms but face translation challenges.
Conclusions:
- Understanding T cell-microglia crosstalk is crucial for MS pathogenesis.
- Modulating these interactions presents a promising therapeutic avenue for MS.
- Further research is needed to bridge preclinical findings with clinical applications in MS treatment.
Related Concept Videos
09:41Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
11:35The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
08:18A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)
08:11Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
09:36Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
08:51Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

